Skip to content

New Method to Close Nasal Septal Perforation

Nasal Septal Perforation Closure Using a 3-dimensional Fabricated Polycaprolactone Nasal Mesh

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06439927
Enrollment
23
Registered
2024-06-03
Start date
2024-08-01
Completion date
2025-12-31
Last updated
2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal Perforated Septum

Keywords

nasal septal perforation

Brief summary

The goal of this clinical trial is to investigate if a 3-dimensional fabricated nasal mesh works to close nasal septal perforations. Under general anesthesia, during nasal septal perforation repair surgery, the investigator will place the mesh between the elevated mucoperichondrial flaps opposite the site of the perforation and confirm its original position at both sides under nasal endoscope. Endoscopic examination for septal mucosa status will be done monthly for a three months follow up period.

Interventions

DEVICEPolycaprolactone nasal mesh

a 3-dimensional fabricated Polycaprolactone nasal mesh

Sponsors

Helwan University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 58 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing nasal septal perforation repair surgery.

Exclusion criteria

* Patients with known allergy to polycaprolactone. * Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in Post-operative healing of septal perforationfor a three months follow up periodEndoscopic evaluation of nasal septal mucosa status will be classified as complete bilateral healing, complete unilateral healing, no healing, and perforation.

Secondary

MeasureTime frameDescription
Postoperative complicationsfor a three months follow up periodThe following complications will be evaluated on a present/absent basis:hematoma-infection-allergy

Countries

Egypt

Contacts

Primary ContactMohamed H Sebaey, Master degree
mohamed.h757@hotmail.com01008306356

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026